Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study.
Oomens JE, van Gils V, Vos SJB, Freeze WM, Maserejian NN, Curiale G, Gillis C, Boada M, van der Flier WM, Hort J, Johnson SC, Lleó A, Ramakers IH, Rodrigue KM, Sánchez-Juan P, Sarazin M, Scarmeas N, Zetterberg H, Alcolea D, Barkhof F, Blennow K, Bottlaender M, den Braber A, Cerman J, Drake-Perez M, Fortea J, Handels R, Ingala S, Jiménez-Bonilla JF, Karavasilis S, Lagarde J, Legdeur N, Lorenzini L, Marquié M, Moonen JEF, Olivieri P, Orellana A, Ossenkoppele R, Rivera-Rivera LA, Rodríguez-Rodriguez E, Ruiz Laza A, Teunissen CE, Tijms BM, Velonakis G, Verhey FRJ, Visser PJ, Jansen WJ; European Prevention of Alzheimer’s Dementia (EPAD) Consortium; Fundació ACE Healthy Brain Initiative (FACEHBI) Study Group; BIOFACE Study Group.
Oomens JE, et al. Among authors: visser pj.
JAMA Netw Open. 2025 Jan 2;8(1):e2455571. doi: 10.1001/jamanetworkopen.2024.55571.
JAMA Netw Open. 2025.
PMID: 39841474